Drug Shortage Report for MYLAN-BECLO AQ

Last updated on 2019-03-09 History
Report ID 14271
Drug Identification Number 02172712
Brand name MYLAN-BECLO AQ
Common or Proper name BECLO AQ
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BECLOMETHASONE DIPROPIONATE
Strength(s) 50MCG
Dosage form(s) METERED-DOSE AEROSOL SUSPENSION
Route of administration NASAL
Packaging size 22s
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-11-07
Actual start date 2018-11-07
Estimated end date 2019-02-28
Actual end date 2019-03-08
Shortage status Resolved
Updated date 2019-03-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-06-28 English Compare
v2 2017-06-28 English Compare
v3 2017-06-28 English Compare
v4 2017-06-28 French Compare
v5 2017-07-12 English Compare
v6 2017-07-12 French Compare
v7 2017-10-06 English Compare
v8 2017-10-06 French Compare
v9 2017-10-13 English Compare
v10 2017-10-13 French Compare
v11 2017-10-13 English Compare
v12 2017-10-13 French Compare
v13 2017-10-16 English Compare
v14 2017-10-16 French Compare
v15 2017-10-17 English Compare
v16 2017-10-18 English Compare
v17 2017-10-18 French Compare
v18 2017-10-19 English Compare
v19 2017-10-19 French Compare
v20 2017-12-04 English Compare

Showing 1 to 20 of 84